The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

BACKGROUND: Neuroendocrine markers, which could indicate for aggressive variants of prostate cancer and Ki67 (a well-known marker in oncology for defining tumor proliferation), have already been associated with clinical outcome in prostate cancer. The aim of this study was to investigate the prognos...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiol Oncol
Main Authors: Pascale, Mariarosa, Aversa, Cinzia, Barbazza, Renzo, Marongiu, Barbara, Siracusano, Salvatore, Stoffel, Flavio, Sulfaro, Sando, Roggero, Enrico, Bonin, Serena, Stanta, Giorgio
Formato: Artigo
Idioma:Inglês
Publicado: De Gruyter 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030813/
https://ncbi.nlm.nih.gov/pubmed/27679548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2016-0033
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares